Global Neurological Biomarkers Market Size, Share Report, Analysis, Trends, Growth 2032
Neurological Biomarkers Market - By Application (Alzheimer’s Disease, Parkinson’s Disease, Autism Spectrum Disorders, Multiple Sclerosis, and Others), By Type (Proteomic, Genomic, Imaging, Metabolomic, and Others), By End-User (Independent Clinical Diagnostic Centers, Hospital Laboratories, Research Organizations, and Others), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast 2024 - 2032-
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 6.12 Billion | USD 21.11 Billion | 13.42% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Neurulogical Biomarkers Market, 2016–2026(USD Million)
- 2.2. Neurulogical Biomarkers Market: Snapshot
- Chapter 3. Global Neurulogical Biomarkers Market– Industry Analysis
- 3.1. Neurulogical Biomarkers Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Large-scale occurrence of the neurulogical ailments due to stressful & hectic work schedule as well as work-life imbalance will drive the market trends.
- 3.2.2. Less proportion of effective diagnostics touls available in emerging countries has resulted in rise in the mortality due to neurulogical diseases, thereby enhancing the need for neurulogical biomarkers in these countries.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Type
- 3.4.2. Market attractiveness analysis By Application
- 3.4.3. Market attractiveness analysis By End-User
- Chapter 4. Global Neurulogical Biomarkers Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Neurulogical Biomarkers Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.2.5. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Neurulogical Biomarkers Market–Application Analysis
- 5.1. Global Neurulogical Biomarkers Market overview: By Application
- 5.1.1. Global Neurulogical Biomarkers Market share, By Application ,2019 and 2026
- 5.2. Alzheimer’s Disease
- 5.2.1. Global Neurulogical Biomarkers Market by Alzheimer’s Disease , 2016–2026(USD Million)
- 5.3. Parkinson’s Disease
- 5.3.1. Global Neurulogical Biomarkers Market by Parkinson’s Disease, 2016–2026(USD Million)
- 5.4. Autism Spectrum Disorders
- 5.4.1. Global Neurulogical Biomarkers Market by Autism Spectrum Disorders, 2016–2026(USD Million)
- 5.5. Multiple Sclerosis
- 5.5.1. Global Neurulogical Biomarkers Market by Multiple Sclerosis, 2016–2026(USD Million)
- 5.6. Others
- 5.6.1. Global Neurulogical Biomarkers Market by Others, 2016–2026(USD Million)
- 5.1. Global Neurulogical Biomarkers Market overview: By Application
- Chapter 6. Global Laser Cutting Machine Market– Type Analysis
- 6.1. Global Neurulogical Biomarkers Market overview: By Type
- 6.1.1. Global Neurulogical Biomarkers Market share, By Type, 2019 and 2026
- 6.2. Proteomic
- 6.2.1. Global Neurulogical Biomarkers Market By Proteomic, 2016–2026(USD Million)
- 6.3. Genomic
- 6.3.1. Global Neurulogical Biomarkers Market By Genomic, 2016–2026(USD Million)
- 6.4. Imaging
- 6.4.1. Global Neurulogical Biomarkers Market By Imaging, 2016–2026(USD Million)
- 6.5. Metabulomic
- 6.5.1. Global Neurulogical Biomarkers Market By Metabulomic, 2016–2026(USD Million)
- 6.6. Others
- 6.6.1. Global Neurulogical Biomarkers Market By Others, 2016–2026(USD Million)
- 6.1. Global Neurulogical Biomarkers Market overview: By Type
- Chapter 7. Global Laser Cutting Machine Market– End-User Analysis
- 7.1. Global Neurulogical Biomarkers Market overview: By End-User
- 7.1.1. Global Neurulogical Biomarkers Market share, By End-User, 2019 and 2026
- 7.2. Independent Clinical Diagnostic Centers
- 7.2.1. Global Neurulogical Biomarkers Market By Independent Clinical Diagnostic Centers, 2016–2026(USD Million)
- 7.3. Hospital Laboratories
- 7.3.1. Global Neurulogical Biomarkers Market By Hospital Laboratories, 2016–2026(USD Million)
- 7.4. Research Organizations
- 7.4.1. Global Neurulogical Biomarkers Market By Research Organizations, 2016–2026(USD Million)
- 7.5. Others
- 7.5.1. Global Neurulogical Biomarkers Market By Others, 2016–2026(USD Million)
- 7.1. Global Neurulogical Biomarkers Market overview: By End-User
- Chapter 8. Company Profiles
- 8.1. QIAGEN
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Abbott
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. Thermo Fisher Scientific Inc.
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Developments
- 8.4. Myriad RBM
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Developments
- 8.5. Bio-Rad Laboratories, Inc.
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. Athena Diagnostics
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Acumen Pharmaceuticals
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. AbaStar MDx, Inc.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. Alseres Pharmaceuticals, Inc.
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.10. BANYAN BIOMARKERS, INC.
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Product Portfolio
- 8.10.4. Business Strategy
- 8.10.5. Recent Development
- 8.1. QIAGEN
Table Of Figures
List of Figures
1. Market research Type
2. Market research methodology
3. Global Neurological Biomarkers Market, 2016–2026(USD Million)
4. Porter’s Five Forces Analysis
5. Global Neurological Biomarkers Market attractiveness, By Type
6. Global Neurological Biomarkers Market attractiveness, By Application
7. Global Neurological Biomarkers Market attractiveness, By End-User
8. Global Neurological Biomarkers Market share, By Application, 2019 and 2026 (USD Million)
9. Global Neurological Biomarkers Market by Alzheimer’s Disease , 2016–2026(USD Million)
10. Global Neurological Biomarkers Market by Parkinson’s Disease,2016–2026(USD Million)
11. Global Neurological Biomarkers Market by Autism Spectrum Disorders,2016–2026(USD Million)
12. Global Neurological Biomarkers Market by Multiple Sclerosis,2016–2026(USD Million)
13. Global Neurological Biomarkers Market by Others,2016–2026(USD Million)
14. Global Neurological Biomarkers Market share by Type,2019 and 2026 (USD Million)
15. Global Neurological Biomarkers Market by Proteomic,2016–2026(USD Million)
16. Global Neurological Biomarkers Market by Genomic,2016–2026(USD Million)
17. Global Neurological Biomarkers Market by Imaging,2016–2026(USD Million)
18. Global Neurological Biomarkers Market by Metabolomic,2016–2026(USD Million)
19. Global Neurological Biomarkers Market by Others,2016–2026(USD Million)
20. Global Neurological Biomarkers Market share by End-User,2019 and 2026 (USD Million)
21. Global Neurological Biomarkers Market by Independent Clinical Diagnostic Centers,2016–2026(USD Million)
22. Global Neurological Biomarkers Market by Hospital Laboratories,2016–2026(USD Million)
23. Global Neurological Biomarkers Market by Research Organizations,2016–2026(USD Million)
24. Global Neurological Biomarkers Market by Others,2016–2026(USD Million)
25. Global Neurological Biomarkers Market share, by Region, 2019 and 2026
26. North America Neurological Biomarkers Market, 2016–2026(USD Million)
27. Europe Neurological Biomarkers Market, 2016–2026(USD Million)
28. Asia Pacific Neurological Biomarkers Market, 2016–2026(USD Million)
29. Latin America Neurological Biomarkers Market, 2016–2026(USD Million)
30. The Middle East and Africa Neurological Biomarkers Market, 2016–2026(USD Million)
Table Of Tables
List of Tables
1. Global Neurological Biomarkers Market: snapshot
2. Drivers of the Neurological Biomarkers Market: impact analysis
3. North America Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
4. North America Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
5. North America Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
6. The U.S. Neurological Biomarkers Market revenue, By Type , 2016–2026(USD Million)
7. The U.S. Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
8. The U.S. Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
9. Rest of North America Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
10. Rest of North America Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
11. Rest of North America Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
12. Europe Neurological Biomarkers Market revenue, By Type , 2016–2026(USD Million)
13. Europe Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
14. Europe Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
15. UK Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
16. UK Neurological Biomarkers Market revenue, By Application, 2016–2026(USD Million)
17. UK Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
18. France Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
19. France Neurological Biomarkers Market revenue, By Application, 2016–2026(USD Million)
20. France Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
21. Germany Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
22. Germany Neurological Biomarkers Market revenue, By Application, 2016–2026(USD Million)
23. Germany Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
24. Rest of Europe Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
25. Rest of Europe Neurological Biomarkers Market revenue, By Application, 2016–2026(USD Million)
26. Rest of Europe Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
27. Asia Pacific Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
28. Asia Pacific Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
29. Asia Pacific Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
30. China Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
31. China Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
32. China Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
33. Japan Neurological Biomarkers Market revenue, By Type , 2016–2026(USD Million)
34. Japan Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
35. Japan Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
36. India Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
37. India Neurological Biomarkers Market revenue, By Application, 2016–2026(USD Million)
38. India Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
39. Rest of Asia Pacific Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
40. Rest of Asia Pacific Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
41. Rest of Asia Pacific Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
42. Latin America Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
43. Latin America Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
44. Latin America Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
45. Brazil Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
46. Brazil Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
47. Brazil Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
48. Rest of Latin America Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
49. Rest of Latin America Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
50. Rest of Latin America Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
51. The Middle East and Africa Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
52. The Middle East and Africa Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
53. The Middle East and Africa Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
54. Saudi Arabia Neurological Biomarkers Market revenue, By Type , 2016–2026(USD Million)
55. Saudi Arabia Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
56. Saudi Arabia Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
57. South Africa Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
58. South Africa Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
59. South Africa Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
60. Rest of the Middle East & Africa Neurological Biomarkers Market revenue, By Type ,2016–2026(USD Million)
61. Rest of the Middle East & Africa Neurological Biomarkers Market revenue, By Application , 2016–2026(USD Million)
62. Rest of the Middle East & Africa Neurological Biomarkers Market revenue, By End-User , 2016–2026(USD Million)
Methodology
FrequentlyAsked Questions
Neurological biomarkers are measurable indicators of brain disorders. They help diagnose and monitor neurological diseases
The global Neurological Biomarkers market is expected to be driven by the rising neurological disorders and demand for early disease diagnosis. Advances in precision medicine and neuro research boost adoption.
According to study, the global Neurological Biomarkers market size was worth around USD 6.12 Billion in 2023 and is predicted to grow to around USD 21.11 Billion By 2032.
The global Neurological Biomarkers market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 13.42% during the forecast period from 2024-2032.
The global Neurological Biomarkers industry is projected to be challenged by Challenges include clinical validation complexity, high R&D costs, and variability in biomarker specificity.
The Opportunities include early diagnosis of neurodegenerative diseases, precision medicine, drug development, and growing neuroscience research funding will offer significant growth opportunities in the Neurological Biomarkers market.
Blood-based and imaging biomarkers for early diagnosis; AI-assisted data interpretation; growing use in personalized neurology and drug development are the emerging trends and innovations impacting the Neurological Biomarkers market.
The global Neurological Biomarkers market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Neurological Biomarkers market are; Bio-Rad Laboratories, Inc., QIAGEN, Alseres Pharmaceuticals, Inc., Abbott, Thermo Fisher Scientific Inc., Acumen Pharmaceuticals, Myriad RBM, Athena Diagnostics; AbaStar MDx, Inc., and BANYAN BIOMARKERS, INC and others.
The report explores crucial aspects of the Neurological Biomarkers market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
